News and Events

Hatchtech Completes $12.6m Capital Raise, Secures Funds for Phase III and NDA Submission

31/10/2013 | Press Releases

Hatchtech today announced the completion of a $12.6m capital raise to fund the Phase III clinical trial and NDA submission.  The company also announced several changes to the composition of its Board.

Download PDF


Categories